Tirzepatide

Tirzepatide – Research Peptide for Advanced Metabolic and Weight Loss Studies
Tirzepatide is a dual GIP and GLP-1 receptor agonist that is gaining increasing attention in metabolic research. Originally developed for the treatment of type 2 diabetes, it is now being studied for its powerful effects on weight loss, appetite regulation, insulin sensitivity, and lipid metabolism. Its multi-receptor action makes it one of the most promising compounds in obesity and metabolic research.

Benefits of Tirzepatide

• Dual GIP and GLP-1 agonism for amplified metabolic effects
• Studied for unmatched appetite suppression and fat loss
• Promotes improved insulin sensitivity and glucose regulation
• May improve cardiovascular and lipid profiles in research models
• Longer half-life than Semaglutide – ideal for weekly dosing protocols
• Emerging interest in preclinical anti-obesity and type 2 diabetes studies

How does Tirzepatide work?
Tirzepatide acts on both GIP and GLP-1 receptors, enhancing insulin secretion, reducing food intake, slowing gastric emptying, and improving glucose tolerance. Researchers are investigating its synergistic effects on energy balance, body weight regulation, and metabolic disease reversal.

Dosage, Preparation & Storage

• Use: Supplied as a lyophilized powder; reconstitute with bacteriostatic water (included)
• Recommended mixing ratio: 1 ml bac water per vial (adjustable based on protocol)
• Use our peptide calculator to achieve precise, reproducible dosages
• Storage: Keep refrigerated (2–8 °C) after mixing
• Shelf life: Stable up to 30 days after reconstitution

Purity & Quality

Each batch is thoroughly tested for purity and sterile production.

Our Semaglutide is produced to the highest standards and tested by an independent third party to ensure maximum purity and quality.

Legal Disclaimer
This product is intended for scientific research use only. It is not approved for human consumption or clinical use.